6-Bromoimidazo[1,2-a]pyridine-3-carboxamide, 97.0%, 10g

3-fluoro-N-(6-sulfanylpyridazin-3-yl)benzamide, 95.0%, 1g

2,4-Difluorophenyl cyclopentyl ketone, 97.0%, 1g

tert-Butyl crotonate, 98.0%, 10g

4,7-Dichloroisobenzofuran-1,3-dione, 95.0%, 1g

3-methyl-4H,7H-thieno[3,2-b]pyridin-7-one, 95%, 1g

Methyl 5-oxohexanoate, 97%, 10g

2-((S)-N-(2,3-Dihydro-1H-inden-2-yl)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanamido)acetic acid hydrochloride, 97%, 1g

2-(2-Bromo-4,5-diethoxyphenyl)acetonitrile, 97%, 250mg

1-(Anthracen-9-yl)-N-methylmethanamine, 95.0%, 25g

Methyl 7-chloro-4-hydroxyquinoline-2-carboxylate, 95.0%, 250mg

2-Amino-4-methoxy-benzothiazole, 97.0%, 5g

Phase contrast Abbe condenser with slide for Plan PLPHi S40 phase contrast infinity corrected objectives, slide with 40x phasing, telescope and green filter